Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P15735: Variant p.Asp215Asn

Phosphorylase b kinase gamma catalytic chain, liver/testis isoform
Gene: PHKG2
Feedback?
Variant information Variant position: help 215 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Aspartate (D) to Asparagine (N) at position 215 (D215N, p.Asp215Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In GSD9C; decrease in phosphorylase b kinase activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 215 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 406 The length of the canonical sequence.
Location on the sequence: help APEILKCSMDETHPGYGKEV D LWACGVILFTLLAGSPPFWH The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH

Mouse                         APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH

Rat                           APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH

Bovine                        APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 406 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform
Domain 24 – 291 Protein kinase
Helix 214 – 228



Literature citations
Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene.
Burwinkel B.; Rootwelt T.; Kvittingen E.A.; Chakraborty P.K.; Kilimann M.W.;
Pediatr. Res. 54:834-839(2003)
Cited for: VARIANTS GSD9C LYS-157 AND ASN-215; A very rare case report of glycogen storage disease type IXc with novel PHKG2 variants.
Shao Y.; Li T.; Jiang M.; Xu J.; Huang Y.; Li X.; Zheng R.; Liu L.;
BMC Pediatr. 22:267-267(2022)
Cited for: VARIANT GSD9C SER-233; CHARACTERIZATION OF VARIANTS GSD9C ASN-215 AND SER-233; VARIANT GLY-253; CHARACTERIZATION OF VARIANT GLY-253; FUNCTION; CATALYTIC ACTIVITY;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.